Pfizer to buy Canadian drug developer Trillium Therapeutics for $2.2B

Filed under: International,News,News/Business |

Pfizer Patient Assistance

Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies.

List your business in the premium web directory for free This website is listed under Human Resources Directory